In ovarian serous carcinoma, positive EphA5 expression is associated with longer survival [17], and in esophageal squamous cell carcinoma, EphA5 knockdown promotes proliferation and invasion through the Wnt/β-catenin pathway [18]. Here, EPHA5 is linked to ovarian serous carcinoma.